Polymeric PARACEST MRI contrast agents as potential reporters for gene therapy

Department of Chemistry, University of Texas at Dallas, P.O. Box 830668, Richardson, Texas 75083, USA.
Organic & Biomolecular Chemistry (Impact Factor: 3.56). 12/2010; 8(23):5333-8. DOI: 10.1039/c0ob00087f
Source: PubMed


Gene therapy is a potentially powerful treatment approach that targets molecular remedies for disease. Among other challenges it remains difficult to monitor gene delivery and its downstream metabolic consequences. Approaches to MRI gene reporters have been reported but few have the potential for translation beyond isolated cell systems. Herein, we report a polycationic polymer MRI contrast agent that binds to DNA in a ratio of one monomer unit per phosphate group of DNA. Significantly, this binding event diminishes the MR contrast signal from the agent itself potentially providing a platform for imaging delivery and release of a gene into cells and tissues. Importantly, we demonstrate here the proof of concept that a positively charged polymeric contrast agent can also act as a transfection agent, delivering the gene for encoding green fluorescent protein into cells. These observations provide support for the radical, new idea of creating a combined transfection/imaging agent for monitoring gene delivery in real time by MRI.

Download full-text


Available from: Christiane E Carney, Sep 09, 2014
9 Reads
  • Source
    • "This mechanism provides an indirect way to detect dilute labile protons that would otherwise be undetectable due to their low concentration. A number of labile proton groups have been investigated for potential clinical translation such as endogenous mobile proteins and peptides in tumor [4] [5] [6] [7] and stroke [8] [9] [10] [11] [12] diagnosis (amide proton transfer (APT)), hydroxyl groups for type 2 diabetes [13] (glyco- CEST), myo-inositol (MI) for Alzheimer's disease [14] (MICEST), iopamidol – an X-ray contrast agent, for pH mapping of kidney (ratiometric CEST) [15] and exogenous paramagnetic CEST (PARA- CEST) agents for monitoring brain neuronal activity [16], detecting enzyme activity [17] and as a potential reporter for gene therapy [18]. Currently, there are two irradiation schemes that can be used to perform the saturation: continuous CEST (CW-CEST) and pulsed- CEST. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Many potential clinical applications of chemical exchange saturation transfer (CEST) have been studied in recent years. However, due to various limitations such as specific absorption rate guidelines and scanner hardware constraints, most of the proposed applications have yet to be translated into routine diagnostic tools. Currently, pulsed CEST which uses multiple short pulses to perform the saturation is the only viable irradiation scheme for clinical translation. However, performing quantitative model-based analysis on pulsed CEST is time consuming because it is necessary to account for the time dependent amplitude of the saturation pulses. As a result, pulsed CEST is generally treated as continuous CEST by finding its equivalent average field or power. Nevertheless, theoretical analysis and simulations reveal that the resulting magnetization is different when the different irradiation schemes are applied. In this study, the quantification of important model parameters such as the amine proton exchange rate from a pulsed CEST experiment using quantitative model-based analyses were examined. Two model-based approaches were considered - discretized and continuous approximation to the time dependent RF irradiation pulses. The results showed that the discretized method was able to fit the experimental data substantially better than its continuous counterpart, but the smaller fitted error of the former did not translate to significantly better fit for the important model parameters. For quantification of the endogenous CEST effect, such as in amide proton transfer imaging, a model-based approach using the average power equivalent saturation can thus be used in place of the discretized approximation.
    Journal of Magnetic Resonance 07/2012; 222(3):88-95. DOI:10.1016/j.jmr.2012.07.003 · 2.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Highlights for 2005 include the characterisation of a number of unusual oxidation state transition metal compounds, such as non-heme Fe(v) and a stable Co(i) species. These compounds can be of particular relevance to oxidation states encountered in biochemical pathways. Another highlight is the exciting study involving protein crystallography that was carried out to determine the first structural example of a cyclam type complex interacting with the protein lysozyme. There have also been many advances in the areas of functional MRI agents and luminescent compounds for cellular sensing.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This chapter reviews the literature reported during 2011 on scandium, yttrium and the lanthanide elements.
    Annual Reports Section A"" (Inorganic Chemistry)""" 01/2012; 108:251-260. DOI:10.1039/c2ic90007f
Show more